Imugene Limited

IUGNF · OTC
Analyze with AI
6/30/2025
6/30/2024
6/30/2023
6/30/2022
Operating Activities
Net Income$0-$150-$38-$38
Dep. & Amort.$0$0$2$2
Deferred Tax$0$0-$10-$12
Stock-Based Comp.$0$0$6$4
Change in WC-$4$3$0-$4
Other Non-Cash-$72$45$10$17
Operating Cash Flow-$76-$102-$30-$31
Investing Activities
PP&E Inv.-$8-$7$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0-$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$5-$0$0-$0
Investing Cash Flow-$13-$7$0-$0
Financing Activities
Debt Repay.$20-$2-$0$0
Stock Issued$0$54$88$109
Stock Repurch.-$1-$3-$5-$6
Dividends Paid$0$0$0$0
Other Fin. Act.-$1$0$0-$2
Financing Cash Flow$17$49$83$101
Forex Effect-$0-$0$0$0
Net Chg. in Cash-$71-$60$53$70
Supplemental Information
Beg. Cash$93$153$100$29
End Cash$22$93$153$100
Free Cash Flow-$90-$109-$30-$31
Imugene Limited (IUGNF) Financial Statements & Key Stats | AlphaPilot